Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cytokine induction pathway is a complex biological process involving the activation of cellular signaling cascades that lead to the synthesis and release of cytokines. This process is typically initiated when pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), detect pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) (Kopitar-Jerala, 2015, PMID: 26161159). Upon ligand binding, these receptors recruit adapter proteins that trigger downstream kinases, including IκB kinase (IKK) and Mitogen-activated protein kinases (MAPKs), eventually activating transcription factors like NF-κB and IRFs (Newton & Dixit, 2012, PMID: 22633361). These transcription factors translocate to the nucleus to induce the expression of pro-inflammatory cytokines such as TNF-α, IL-1, and IL-6. In healthy states, this pathway is critical for mounting an effective immune response against pathogens and promoting tissue repair. However, chronic or excessive activation of cytokine induction pathways is a hallmark of numerous pathologies, including rheumatoid arthritis, inflammatory bowel disease, and life-threatening conditions like septic shock or cytokine release syndrome (CRS) (Dinarello, 2007, PMID: 17548043). Pharmacological intervention typically targets specific nodes within these pathways, such as cytokine receptors or intracellular signaling enzymes (e.g., Janus kinases), to modulate the inflammatory environment. Because 'Cytokine induction pathway activation' describes a broad physiological sequence involving hundreds of distinct molecular entities rather than a single druggable protein, it is characterized as a biological process rather than a specific therapeutic target (Chousterman et al., 2017, PMID: 28362200).
Modulation of intracellular signaling cascades (such as NF-κB, JAK-STAT, or MAPK pathways) to either inhibit or stimulate the transcription, translation, and secretion of various cytokines.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytokine induction pathway.